Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hamilton

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Oncotarget|July 21, 2016
A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort studyPedro Castelo-Branco, Ricardo Leão, Tatiana Lipman, et al.
Heart Rhythm|July 27, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset CancerRobert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 25, 2008
Allergy diagnostic testing: an updated practice parameterI Leonard Bernstein, James T Li, David I Bernstein, et al.
The Journal of Urology|January 3, 2022
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC SubstudyJehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, et al.
Journal of the American College of Cardiology|February 24, 2009
Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapiesKathryn K Collins, George F Van Hare, Naomi J Kertesz, et al.
JAMA Cardiology|November 3, 2021
Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency SyndromeThomas M Roston, Jinhong Wei, Wenting Guo, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Oncotarget|July 21, 2016
A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort studyPedro Castelo-Branco, Ricardo Leão, Tatiana Lipman, et al.
Heart Rhythm|July 27, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
BJU International|November 19, 2025
Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancerKeiran J C Pace, Jethro C C Kwong, Harkanwal Randhawa, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 4, 2011
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Michael J Ackerman, Silvia G Priori, Stephan Willems, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset CancerRobert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 25, 2008
Allergy diagnostic testing: an updated practice parameterI Leonard Bernstein, James T Li, David I Bernstein, et al.
The Journal of Urology|January 3, 2022
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC SubstudyJehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, et al.
Journal of the American College of Cardiology|February 24, 2009
Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapiesKathryn K Collins, George F Van Hare, Naomi J Kertesz, et al.
JAMA Cardiology|November 3, 2021
Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency SyndromeThomas M Roston, Jinhong Wei, Wenting Guo, et al.
Pageof 15